Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Puntoni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Lipid Research|March 15, 2012
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresisM P Adorni, F Zimetti, M Puntoni, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2015
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CTA Piccardo, M Puntoni, S Morbelli, et al.
Journal of Chemotherapy (Florence, Italy)|February 10, 2011
Administration interval and daptomycin toxicity: a case report of rhabdomyolysisF Sbrana, A Di Paolo, E M Pasanisi, et al.
British Journal of Cancer|October 26, 2013
The effect of metformin on apoptosis in a breast cancer presurgical trialM Cazzaniga, A DeCensi, G Pruneri, et al.
European Journal of Endocrinology|March 12, 2016
Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histologyA Piccardo, M Puntoni, G Treglia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2018
Additional value of integrated Arnoldo Piccardo, P Trimboli, M Rutigliani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2024
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) CT/PETA Gennari, E Brain, A De Censi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Lipid Research|March 15, 2012
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresisM P Adorni, F Zimetti, M Puntoni, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2015
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CTA Piccardo, M Puntoni, S Morbelli, et al.
Journal of Chemotherapy (Florence, Italy)|February 10, 2011
Administration interval and daptomycin toxicity: a case report of rhabdomyolysisF Sbrana, A Di Paolo, E M Pasanisi, et al.
British Journal of Cancer|October 26, 2013
The effect of metformin on apoptosis in a breast cancer presurgical trialM Cazzaniga, A DeCensi, G Pruneri, et al.
European Journal of Endocrinology|March 12, 2016
Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histologyA Piccardo, M Puntoni, G Treglia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 17, 2018
Additional value of integrated Arnoldo Piccardo, P Trimboli, M Rutigliani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 29, 2024
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) CT/PETA Gennari, E Brain, A De Censi, et al.
Pageof 2